These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
499 related articles for article (PubMed ID: 17391316)
1. Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study. Valenti L; Fracanzani AL; Dongiovanni P; Bugianesi E; Marchesini G; Manzini P; Vanni E; Fargion S Am J Gastroenterol; 2007 Jun; 102(6):1251-8. PubMed ID: 17391316 [TBL] [Abstract][Full Text] [Related]
2. Hyperferritinemia is associated with insulin resistance and fatty liver in patients without iron overload. Brudevold R; Hole T; Hammerstrøm J PLoS One; 2008; 3(10):e3547. PubMed ID: 18958176 [TBL] [Abstract][Full Text] [Related]
3. Iron overload in patients receiving allogeneic hematopoietic stem cell transplantation: quantification of iron burden by a superconducting quantum interference device (SQUID) and therapeutic effectiveness of phlebotomy. Busca A; Falda M; Manzini P; D'Antico S; Valfrè A; Locatelli F; Calabrese R; Chiappella A; D'Ardia S; Longo F; Piga A Biol Blood Marrow Transplant; 2010 Jan; 16(1):115-22. PubMed ID: 19766730 [TBL] [Abstract][Full Text] [Related]
4. Glucose abnormalities in non-alcoholic fatty liver disease and chronic hepatitis C virus infection: the role of iron overload. Lecube A; Hernández C; Simó R Diabetes Metab Res Rev; 2009 Jul; 25(5):403-10. PubMed ID: 19444865 [TBL] [Abstract][Full Text] [Related]
5. Alpha 1-antitrypsin mutations in NAFLD: high prevalence and association with altered iron metabolism but not with liver damage. Valenti L; Dongiovanni P; Piperno A; Fracanzani AL; Maggioni M; Rametta R; Loria P; Casiraghi MA; Suigo E; Ceriani R; Remondini E; Trombini P; Fargion S Hepatology; 2006 Oct; 44(4):857-64. PubMed ID: 17006922 [TBL] [Abstract][Full Text] [Related]
6. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis. Bugianesi E; Marchesini G; Gentilcore E; Cua IH; Vanni E; Rizzetto M; George J Hepatology; 2006 Dec; 44(6):1648-55. PubMed ID: 17133473 [TBL] [Abstract][Full Text] [Related]
7. Associations between liver histology and cortisol secretion in subjects with nonalcoholic fatty liver disease. Targher G; Bertolini L; Rodella S; Zoppini G; Zenari L; Falezza G Clin Endocrinol (Oxf); 2006 Mar; 64(3):337-41. PubMed ID: 16487446 [TBL] [Abstract][Full Text] [Related]
8. Associations between plasma adiponectin concentrations and liver histology in patients with nonalcoholic fatty liver disease. Targher G; Bertolini L; Rodella S; Zoppini G; Scala L; Zenari L; Falezza G Clin Endocrinol (Oxf); 2006 Jun; 64(6):679-83. PubMed ID: 16712671 [TBL] [Abstract][Full Text] [Related]
9. Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study. Nobili V; Manco M; Ciampalini P; Alisi A; Devito R; Bugianesi E; Marcellini M; Marchesini G Clin Ther; 2008 Jun; 30(6):1168-76. PubMed ID: 18640473 [TBL] [Abstract][Full Text] [Related]
10. Increased urinary excretion of 8-iso-prostaglandin F2alpha in patients with HFE-related hemochromatosis: a case-control study. Kom GD; Schwedhelm E; Nielsen P; Böger RH Free Radic Biol Med; 2006 Apr; 40(7):1194-200. PubMed ID: 16545687 [TBL] [Abstract][Full Text] [Related]
11. Effects of venesections and restricted diet in patients with the insulin-resistance hepatic iron overload syndrome. Piperno A; Vergani A; Salvioni A; Trombini P; Viganò M; Riva A; Zoppo A; Boari G; Mancia G Liver Int; 2004 Oct; 24(5):471-6. PubMed ID: 15482345 [TBL] [Abstract][Full Text] [Related]
13. Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease. Targher G; Bertolini L; Padovani R; Rodella S; Zoppini G; Zenari L; Cigolini M; Falezza G; Arcaro G Diabetes Care; 2006 Jun; 29(6):1325-30. PubMed ID: 16732016 [TBL] [Abstract][Full Text] [Related]
14. Copper availability contributes to iron perturbations in human nonalcoholic fatty liver disease. Aigner E; Theurl I; Haufe H; Seifert M; Hohla F; Scharinger L; Stickel F; Mourlane F; Weiss G; Datz C Gastroenterology; 2008 Aug; 135(2):680-8. PubMed ID: 18505688 [TBL] [Abstract][Full Text] [Related]
15. Relationship between insulin resistance and serum alanine aminotransferase as a surrogate of NAFLD (nonalcoholic fatty liver disease) in obese Korean children. Yoo J; Lee S; Kim K; Yoo S; Sung E; Yim J Diabetes Res Clin Pract; 2008 Sep; 81(3):321-6. PubMed ID: 18571268 [TBL] [Abstract][Full Text] [Related]
16. Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis. Fargion S; Mattioli M; Fracanzani AL; Sampietro M; Tavazzi D; Fociani P; Taioli E; Valenti L; Fiorelli G Am J Gastroenterol; 2001 Aug; 96(8):2448-55. PubMed ID: 11513189 [TBL] [Abstract][Full Text] [Related]
17. Hepatic iron concentration in hereditary hemochromatosis does not saturate or accurately predict phlebotomy requirements. Olynyk JK; Luxon BA; Britton RS; Bacon BR Am J Gastroenterol; 1998 Mar; 93(3):346-50. PubMed ID: 9517637 [TBL] [Abstract][Full Text] [Related]
18. The hepatic response to FGF19 is impaired in patients with nonalcoholic fatty liver disease and insulin resistance. Schreuder TC; Marsman HA; Lenicek M; van Werven JR; Nederveen AJ; Jansen PL; Schaap FG Am J Physiol Gastrointest Liver Physiol; 2010 Mar; 298(3):G440-5. PubMed ID: 20093562 [TBL] [Abstract][Full Text] [Related]
19. Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with Adult Treatment Panel III criteria in nonobese nondiabetic subjects. Musso G; Gambino R; Bo S; Uberti B; Biroli G; Pagano G; Cassader M Diabetes Care; 2008 Mar; 31(3):562-8. PubMed ID: 18056890 [TBL] [Abstract][Full Text] [Related]
20. Effect of phlebotomy on lipid metabolism in subjects with hereditary hemochromatosis. Casanova-Esteban P; Guiral N; Andrés E; Gonzalvo C; Mateo-Gallego R; Giraldo P; Paramo JA; Civeira F Metabolism; 2011 Jun; 60(6):830-4. PubMed ID: 20846699 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]